Pliant Therapeutics (PLRX) Net Margin (2020 - 2023)
Pliant Therapeutics (PLRX) posted quarterly Net Margin of 16609.68% for Q2 2023, down 1601745.0% year-over-year from N/an in Q2 2022, and down 489.22% quarter-over-quarter from 2818.92% in Q1 2023.
Pliant Therapeutics (PLRX) Net Margin (2020 - 2023) Analysis & Trends
Pliant Therapeutics (PLRX) has reported Net Margin for 4 consecutive years, with 16609.68% the latest figure, recorded in Q2 2023.
- In Q2 2023, Net Margin fell 1601745.0% year-over-year to 16609.68%; the TTM figure through Mar 2024 stood at 80358.06% (down 7899884.0% YoY), while the FY2023 annual figure was 21252.09%, down 1997877.0% from the prior year.
- Net Margin retreated to 16609.68% in Q2 2023 per PLRX's latest filing, from 2818.92% in the prior quarter.
- Across five years, Net Margin topped out at 343.46% in Q3 2020 and bottomed at 16609.68% in Q2 2023.
- Historically, Net Margin has averaged 2507.82% across 4 years, with a median of 1276.19% in 2021.
- Annual changes were most pronounced in 2022 — Net Margin soared 68396 bps — and 2023, when it tumbled 1601745 bps.
- Pliant Therapeutics' Net Margin stood at 430.77% in 2020, then plunged by 185 bps to 1227.16% in 2021, then slumped by 45 bps to 1784.22% in 2022, then slumped by 831 bps to 16609.68% in 2023.
- Business Quant data shows PLRX's Net Margin at 16609.68% in Q2 2023, 2818.92% in Q1 2023, and 1784.22% in Q4 2022.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | 32.99% |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | 30.23% |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | 31.16% |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | -539.31% |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | 13.90% |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | 12.74% |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | -3.12% |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | 12.09% |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | -16.51% |
| 10 | Pliant Therapeutics | 70.59 Mn | 70.59 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2023 | -16,609.68% |
| Mar 31, 2023 | -2,818.92% |
| Dec 31, 2022 | -1,784.22% |
| Sep 30, 2022 | -2,065.79% |
| Jun 30, 2022 | -592.22% |
| Mar 31, 2022 | -2,249.80% |
| Dec 31, 2021 | -1,227.16% |
| Sep 30, 2021 | -1,679.81% |
| Jun 30, 2021 | -1,276.19% |
| Mar 31, 2021 | -1,051.33% |
| Dec 31, 2020 | -430.77% |
| Sep 30, 2020 | -343.46% |
| Jun 30, 2020 | -472.25% |